⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for atm

Every month we try and update this database with for atm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02975934
Metastatic Cast...
Rucaparib
Abiraterone ace...
18 Years - pharmaand GmbH
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer PatientsNCT05002140
Metastasis
Locally Advance...
Recurrent Cance...
XRD-0394
Palliative radi...
18 Years - XRad Therapeutics Inc
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyNCT02975934
Metastatic Cast...
Rucaparib
Abiraterone ace...
18 Years - pharmaand GmbH
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)NCT03075735
Prostate Cancer
18 Years - 99 YearsCentro Nacional de Investigaciones Oncologicas CARLOS III
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)NCT03075735
Prostate Cancer
18 Years - 99 YearsCentro Nacional de Investigaciones Oncologicas CARLOS III
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer PatientsNCT05002140
Metastasis
Locally Advance...
Recurrent Cance...
XRD-0394
Palliative radi...
18 Years - XRad Therapeutics Inc
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)NCT03075735
Prostate Cancer
18 Years - 99 YearsCentro Nacional de Investigaciones Oncologicas CARLOS III
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer PatientsNCT05002140
Metastasis
Locally Advance...
Recurrent Cance...
XRD-0394
Palliative radi...
18 Years - XRad Therapeutics Inc
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: